2020
DOI: 10.3233/jpd-201969
|View full text |Cite
|
Sign up to set email alerts
|

Gait Kinematic Parameters in Parkinson’s Disease: A Systematic Review

Abstract: Background: Gait impairments are common and highly disabling for Parkinson's disease (PD) patients. With the development of technology-based tools, it is now possible to measure the spatiotemporal parameters of gait with a reduced margin of error, thereby enabling a more accurate characterization of impairment. Objective: To summarize and critically appraise the characteristics of technology-based gait analysis in PD and to provide mean and standard deviation values for spatiotemporal gait parameters. Methods:… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
35
0
5

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 40 publications
(44 citation statements)
references
References 19 publications
0
35
0
5
Order By: Relevance
“…Stride time variability is defined using the ratio of the SD of the stride times to the mean stride time within each walking trial. Longer stride time and greater stride time variability within a given walking condition (ie, single or dual task) have each been associated with aging [ 21 ], incidence of movement disorders (including PD) [ 22 ], the development of falls [ 3 ], and even the likelihood of future cognitive decline [ 23 ]. We also calculated the dual-task “costs” to stride time and stride time variability as the percent change of each metric from the single- to dual-task walking condition.…”
Section: Methodsmentioning
confidence: 99%
“…Stride time variability is defined using the ratio of the SD of the stride times to the mean stride time within each walking trial. Longer stride time and greater stride time variability within a given walking condition (ie, single or dual task) have each been associated with aging [ 21 ], incidence of movement disorders (including PD) [ 22 ], the development of falls [ 3 ], and even the likelihood of future cognitive decline [ 23 ]. We also calculated the dual-task “costs” to stride time and stride time variability as the percent change of each metric from the single- to dual-task walking condition.…”
Section: Methodsmentioning
confidence: 99%
“…Step length and stride length (twice the step length) are two important measurements in many applications such as gait analysis and human activity recognition. As shown in [ 82 ], the increased fear of falling score was associated with increased stride length variability, and compared to heathy adults, people with PD show a reduction in their stride length [ 83 ].…”
Section: Resultsmentioning
confidence: 99%
“…Einige Gruppen verwenden an beiden Armen und Beinen Sensoren, andere nur am Handgelenk, wieder andere lediglich einen Bauchgurt oder Sensoren, die am Schuh angebracht werden [16]. [8] verglichen in einem systematischen Review Accelerometer vs. verschiedene andere Sensoren, in der Subgruppenanalyse zeigten sich keine signifikanten Unterschiede, alle Systeme konnten signifikant zwischen PmMP und gesunden Kontrollen unterscheiden, ein signifikanter Unterschied in Abhängigkeit von der Position der angebrachten Sensoren wurde auch nicht gefunden.…”
Section: Symptom Monitoring Und Therapieüberwachung Von Ms Und Nmsunclassified
“…Neben dem FOG Questionnaire und klinischen Untersuchungen wie dem TUG-Test werden in den letzten Jahren zunehmend Studien zu Wearables durchgeführt [8]. In der sehr umfassenden Übersichtsarbeit von Silva di Lima et al werden die verschiedenen Sensoren und deren Studienlage zusammengefasst [30].…”
Section: Freezing Of Gait (Fog)unclassified
See 1 more Smart Citation